Rachel John, NP

Rachel John practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Rachel John's NPI, 1699348805, was assigned on July 24, 2021. Rachel John holds Texas license 1046033.

Rachel John's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Rachel John's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is IMED Physician Network. Dmand AI also links Rachel John to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachel John practices. Vendor and product names are available with a free account.

Acute care is Rachel John's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Rachel John is licensed in Texas.

CMS counts 56 Medicare patients who saw Rachel John in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rachel John's median patient age at 29, with 100% women.

In 2024, Rachel John wrote 164 Medicare Part D claims for 32 patients. 82% of them were for generic drugs.

CMS Open Payments shows 1 general payment to Rachel John from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Averitas Pharma Inc. paid the most, $20.